Back to search
FDAFDA · Food and drugs·Recall number D-0882-2022

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

Published May 25, 2022 · Recall initiated: April 5, 2022

Summary

FDA records drug Class I recall D-0882-2022, published May 25, 2022 and initiated April 5, 2022. Recalling firm: Cardinal Health Inc.; Status: Completed; Reported quantity: 1 box; Lot: Unknown. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

What to do

Voluntary: Firm initiated · Letter

Get an email if HUMALOG has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HUMALOG
Manufacturer
Cardinal Health Inc.
Distributor
NM only
Lot
Unknown
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59 recalled?

Yes. FDA published recall D-0882-2022 on May 25, 2022. Reported hazard: TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HUMALOG.